Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor - PubMed (original) (raw)
Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor
T Doi et al. Proc Natl Acad Sci U S A. 1992.
Abstract
Renal disease is one of the most common and severe complications of diabetes mellitus. The hallmark of the disease, glomerulosclerosis, is characterized by an accumulation of extracellular matrix in the mesangial areas, leading to progressive obliteration of the vascular spaces. The role of the metabolic derangements of diabetes mellitus in the development of these lesions is incompletely understood. One of the consequences of hyperglycemia is the formation of advanced glycosylation end products (AGEs), which result from a series of rearrangements secondary to nonenzymatic reaction of glucose with proteins. Specific receptors for proteins modified by AGEs, present in several cell types, were recently described in human and rat mesangial cells. Furthermore, exposure of mesangial cells to AGEs was followed by an increase in fibronectin production. In the present study we show evidence that mouse mesangial cells exhibit an increase in collagen type IV mRNA and peptide synthesis after exposure to AGEs. Antibodies to AGE receptors prevent this increase, indicating that the response is AGE-receptor-mediated. In addition, anti-platelet-derived growth factor abrogates the AGE response, suggesting that platelet-derived growth factor acts as an intermediate factor. Transcription assay reveals that the elevated mRNA levels are due to an increase in the transcription rate, rather than to an increase in the stability of the message. Finally, the mRNAs coding for laminin and heparan sulfate proteoglycan are also increased after exposure to AGE, whereas glyceraldehyde 3-phosphate dehydrogenase mRNA levels remain constant. The increase in extracellular matrix mRNAs seen in the current study suggests that AGE formation in vivo may be one of the metabolic events leading to the development of diabetic glomerulosclerosis.
Similar articles
- Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism.
Pugliese G, Pricci F, Romeo G, Pugliese F, Mené P, Giannini S, Cresci B, Galli G, Rotella CM, Vlassara H, Di Mario U. Pugliese G, et al. Diabetes. 1997 Nov;46(11):1881-7. doi: 10.2337/diab.46.11.1881. Diabetes. 1997. PMID: 9356040 - PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products.
Throckmorton DC, Brogden AP, Min B, Rasmussen H, Kashgarian M. Throckmorton DC, et al. Kidney Int. 1995 Jul;48(1):111-7. doi: 10.1038/ki.1995.274. Kidney Int. 1995. PMID: 7564067 - Chrysin Inhibits Advanced Glycation End Products-Induced Kidney Fibrosis in Renal Mesangial Cells and Diabetic Kidneys.
Lee EJ, Kang MK, Kim DY, Kim YH, Oh H, Kang YH. Lee EJ, et al. Nutrients. 2018 Jul 9;10(7):882. doi: 10.3390/nu10070882. Nutrients. 2018. PMID: 29987200 Free PMC article. - [Glomerular extracellular matrix in glomerulosclerosis by molecular biology].
Makino H. Makino H. Nihon Rinsho. 1992 Dec;50(12):3038-45. Nihon Rinsho. 1992. PMID: 1491457 Review. Japanese. - Role of Smad1 in diabetic nephropathy: Molecular mechanisms and implications as a diagnostic marker.
Abe H, Matsubara T, Arai H, Doi T. Abe H, et al. Histol Histopathol. 2011 Apr;26(4):531-41. doi: 10.14670/HH-26.531. Histol Histopathol. 2011. PMID: 21360446 Review.
Cited by
- Biomarkers of Oxidative Stress in Diabetes Mellitus with Diabetic Nephropathy Complications.
Goycheva P, Petkova-Parlapanska K, Georgieva E, Karamalakova Y, Nikolova G. Goycheva P, et al. Int J Mol Sci. 2023 Aug 31;24(17):13541. doi: 10.3390/ijms241713541. Int J Mol Sci. 2023. PMID: 37686346 Free PMC article. - Myeloproliferative Neoplasm and Myelodysplastic Syndrome-Associated Renal Disease: A Histopathological Report of Two Cases.
Popov H, Koleva T, Stoyanov GS, Ghenev P. Popov H, et al. Cureus. 2022 Dec 10;14(12):e32388. doi: 10.7759/cureus.32388. eCollection 2022 Dec. Cureus. 2022. PMID: 36632253 Free PMC article. - Axl Expression in Renal Mesangial Cells Is Regulated by Sp1, Ap1, MZF1, and Ep300, and the IL-6/miR-34a Pathway.
Adams DE, Zhen Y, Qi X, Shao WH. Adams DE, et al. Cells. 2022 Jun 9;11(12):1869. doi: 10.3390/cells11121869. Cells. 2022. PMID: 35740998 Free PMC article. - Mesangioproliferative Kidney Diseases and Platelet-Derived Growth Factor-Mediated AXL Phosphorylation.
Bian Q, Anderson JC, Zhang XW, Huang ZQ, Ebefors K, Nyström J, Hall S, Novak L, Julian BA, Willey CD, Novak J. Bian Q, et al. Kidney Med. 2021 Jul 30;3(6):1003-1013.e1. doi: 10.1016/j.xkme.2021.06.007. eCollection 2021 Nov-Dec. Kidney Med. 2021. PMID: 34939009 Free PMC article. - NF-κB System Is Chronically Activated and Promotes Glomerular Injury in Experimental Type 1 Diabetic Kidney Disease.
Foresto-Neto O, Albino AH, Arias SCA, Faustino VD, Zambom FFF, Cenedeze MA, Elias RM, Malheiros DMAC, Camara NOS, Fujihara CK, Zatz R. Foresto-Neto O, et al. Front Physiol. 2020 Feb 11;11:84. doi: 10.3389/fphys.2020.00084. eCollection 2020. Front Physiol. 2020. PMID: 32116790 Free PMC article.
References
- J Biol Chem. 1988 Nov 15;263(32):16536-44 - PubMed
- Am J Pathol. 1988 Jun;131(3):398-403 - PubMed
- N Engl J Med. 1988 May 19;318(20):1315-21 - PubMed
- Proc Natl Acad Sci U S A. 1987 Feb;84(4):935-9 - PubMed
- Hum Pathol. 1985 May;16(5):477-84 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials